NCT04275284View on ClinicalTrials.gov

Persistence of Immunogenicity Following Reduced PCV Dosing Schedules in South African Children

CompletedOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

February 14, 2020

Primary Completion Date

December 1, 2022

Study Completion Date

December 1, 2022

Conditions
PneumoniaMeningitis
Interventions
BIOLOGICAL

PCV10

0.5 ml injection

BIOLOGICAL

PCV13

0.5 ml injection

Trial Locations (1)

2013

Chris Hani Baragwanath Academic Hospital - DST/NRF VPD RMPRU, Soweto

All Listed Sponsors
lead

University of Witwatersrand, South Africa

OTHER

NCT04275284 - Persistence of Immunogenicity Following Reduced PCV Dosing Schedules in South African Children | Biotech Hunter | Biotech Hunter